- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Remicade Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Remicade Biosimilar market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Blood Disorders accounting for % of the Remicade Biosimilar global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 100mg/10ml segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Remicade Biosimilar include Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, and Biocon, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Remicade Biosimilar market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100mg/10ml
500mg/50ml
Market segment by Application can be divided into
Blood Disorders
Oncology Diseases
The key market players for global Remicade Biosimilar market are listed below:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Remicade Biosimilar product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Remicade Biosimilar, with price, sales, revenue and global market share of Remicade Biosimilar from 2019 to 2022.
Chapter 3, the Remicade Biosimilar competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Remicade Biosimilar breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Remicade Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Remicade Biosimilar.
Chapter 13, 14, and 15, to describe Remicade Biosimilar sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Remicade Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Remicade Biosimilar Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Remicade Biosimilar Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Global Remicade Biosimilar Market Size & Forecast
1.4.1 Global Remicade Biosimilar Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Remicade Biosimilar Sales in Volume (2017-2028)
1.4.3 Global Remicade Biosimilar Price (2017-2028)
1.5 Global Remicade Biosimilar Production Capacity Analysis
1.5.1 Global Remicade Biosimilar Total Production Capacity (2017-2028)
1.5.2 Global Remicade Biosimilar Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Remicade Biosimilar Market Drivers
1.6.2 Remicade Biosimilar Market Restraints
1.6.3 Remicade Biosimilar Trends Analysis
2 Manufacturers Profiles
2.1 Synthon Pharmaceuticals
2.1.1 Synthon Pharmaceuticals Details
2.1.2 Synthon Pharmaceuticals Major Business
2.1.3 Synthon Pharmaceuticals Remicade Biosimilar Product and Services
2.1.4 Synthon Pharmaceuticals Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 LG Life Sciences
2.2.1 LG Life Sciences Details
2.2.2 LG Life Sciences Major Business
2.2.3 LG Life Sciences Remicade Biosimilar Product and Services
2.2.4 LG Life Sciences Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis (Sandoz)
2.3.1 Novartis (Sandoz) Details
2.3.2 Novartis (Sandoz) Major Business
2.3.3 Novartis (Sandoz) Remicade Biosimilar Product and Services
2.3.4 Novartis (Sandoz) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Celltrion
2.4.1 Celltrion Details
2.4.2 Celltrion Major Business
2.4.3 Celltrion Remicade Biosimilar Product and Services
2.4.4 Celltrion Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biocon
2.5.1 Biocon Details
2.5.2 Biocon Major Business
2.5.3 Biocon Remicade Biosimilar Product and Services
2.5.4 Biocon Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hospira
2.6.1 Hospira Details
2.6.2 Hospira Major Business
2.6.3 Hospira Remicade Biosimilar Product and Services
2.6.4 Hospira Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck Serono (Merck Group)
2.7.1 Merck Serono (Merck Group) Details
2.7.2 Merck Serono (Merck Group) Major Business
2.7.3 Merck Serono (Merck Group) Remicade Biosimilar Product and Services
2.7.4 Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biogen idec Inc.
2.8.1 Biogen idec Inc. Details
2.8.2 Biogen idec Inc. Major Business
2.8.3 Biogen idec Inc. Remicade Biosimilar Product and Services
2.8.4 Biogen idec Inc. Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Genentech (Roche Group)
2.9.1 Genentech (Roche Group) Details
2.9.2 Genentech (Roche Group) Major Business
2.9.3 Genentech (Roche Group) Remicade Biosimilar Product and Services
2.9.4 Genentech (Roche Group) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Fosun Pharmaceutical
2.10.1 Fosun Pharmaceutical Details
2.10.2 Fosun Pharmaceutical Major Business
2.10.3 Fosun Pharmaceutical Remicade Biosimilar Product and Services
2.10.4 Fosun Pharmaceutical Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Livzon Pharmaceutical
2.11.1 Livzon Pharmaceutical Details
2.11.2 Livzon Pharmaceutical Major Business
2.11.3 Livzon Pharmaceutical Remicade Biosimilar Product and Services
2.11.4 Livzon Pharmaceutical Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Anke Biotechnology
2.12.1 Anke Biotechnology Details
2.12.2 Anke Biotechnology Major Business
2.12.3 Anke Biotechnology Remicade Biosimilar Product and Services
2.12.4 Anke Biotechnology Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Hualan Biological Engineering
2.13.1 Hualan Biological Engineering Details
2.13.2 Hualan Biological Engineering Major Business
2.13.3 Hualan Biological Engineering Remicade Biosimilar Product and Services
2.13.4 Hualan Biological Engineering Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Walvax Biotechnology
2.14.1 Walvax Biotechnology Details
2.14.2 Walvax Biotechnology Major Business
2.14.3 Walvax Biotechnology Remicade Biosimilar Product and Services
2.14.4 Walvax Biotechnology Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Hisun Pharmaceutical
2.15.1 Hisun Pharmaceutical Details
2.15.2 Hisun Pharmaceutical Major Business
2.15.3 Hisun Pharmaceutical Remicade Biosimilar Product and Services
2.15.4 Hisun Pharmaceutical Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Remicade Biosimilar Breakdown Data by Manufacturer
3.1 Global Remicade Biosimilar Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Remicade Biosimilar Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Remicade Biosimilar
3.4 Market Concentration Rate
3.4.1 Top 3 Remicade Biosimilar Manufacturer Market Share in 2021
3.4.2 Top 6 Remicade Biosimilar Manufacturer Market Share in 2021
3.5 Global Remicade Biosimilar Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Remicade Biosimilar Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Remicade Biosimilar Market Size by Region
4.1.1 Global Remicade Biosimilar Sales in Volume by Region (2017-2028)
4.1.2 Global Remicade Biosimilar Revenue by Region (2017-2028)
4.2 North America Remicade Biosimilar Revenue (2017-2028)
4.3 Europe Remicade Biosimilar Revenue (2017-2028)
4.4 Asia-Pacific Remicade Biosimilar Revenue (2017-2028)
4.5 South America Remicade Biosimilar Revenue (2017-2028)
4.6 Middle East and Africa Remicade Biosimilar Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Remicade Biosimilar Sales in Volume by Type (2017-2028)
5.2 Global Remicade Biosimilar Revenue by Type (2017-2028)
5.3 Global Remicade Biosimilar Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Remicade Biosimilar Sales in Volume by Application (2017-2028)
6.2 Global Remicade Biosimilar Revenue by Application (2017-2028)
6.3 Global Remicade Biosimilar Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Remicade Biosimilar Sales by Type (2017-2028)
7.2 North America Remicade Biosimilar Sales by Application (2017-2028)
7.3 North America Remicade Biosimilar Market Size by Country
7.3.1 North America Remicade Biosimilar Sales in Volume by Country (2017-2028)
7.3.2 North America Remicade Biosimilar Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Remicade Biosimilar Sales by Type (2017-2028)
8.2 Europe Remicade Biosimilar Sales by Application (2017-2028)
8.3 Europe Remicade Biosimilar Market Size by Country
8.3.1 Europe Remicade Biosimilar Sales in Volume by Country (2017-2028)
8.3.2 Europe Remicade Biosimilar Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Remicade Biosimilar Sales by Type (2017-2028)
9.2 Asia-Pacific Remicade Biosimilar Sales by Application (2017-2028)
9.3 Asia-Pacific Remicade Biosimilar Market Size by Region
9.3.1 Asia-Pacific Remicade Biosimilar Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Remicade Biosimilar Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Remicade Biosimilar Sales by Type (2017-2028)
10.2 South America Remicade Biosimilar Sales by Application (2017-2028)
10.3 South America Remicade Biosimilar Market Size by Country
10.3.1 South America Remicade Biosimilar Sales in Volume by Country (2017-2028)
10.3.2 South America Remicade Biosimilar Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Remicade Biosimilar Sales by Type (2017-2028)
11.2 Middle East & Africa Remicade Biosimilar Sales by Application (2017-2028)
11.3 Middle East & Africa Remicade Biosimilar Market Size by Country
11.3.1 Middle East & Africa Remicade Biosimilar Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Remicade Biosimilar Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Remicade Biosimilar and Key Manufacturers
12.2 Manufacturing Costs Percentage of Remicade Biosimilar
12.3 Remicade Biosimilar Production Process
12.4 Remicade Biosimilar Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Remicade Biosimilar Typical Distributors
13.3 Remicade Biosimilar Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Remicade Biosimilar Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Remicade Biosimilar Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Synthon Pharmaceuticals Major Business
Table 5. Synthon Pharmaceuticals Remicade Biosimilar Product and Services
Table 6. Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 8. LG Life Sciences Major Business
Table 9. LG Life Sciences Remicade Biosimilar Product and Services
Table 10. LG Life Sciences Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis (Sandoz) Basic Information, Manufacturing Base and Competitors
Table 12. Novartis (Sandoz) Major Business
Table 13. Novartis (Sandoz) Remicade Biosimilar Product and Services
Table 14. Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Celltrion Basic Information, Manufacturing Base and Competitors
Table 16. Celltrion Major Business
Table 17. Celltrion Remicade Biosimilar Product and Services
Table 18. Celltrion Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biocon Basic Information, Manufacturing Base and Competitors
Table 20. Biocon Major Business
Table 21. Biocon Remicade Biosimilar Product and Services
Table 22. Biocon Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hospira Basic Information, Manufacturing Base and Competitors
Table 24. Hospira Major Business
Table 25. Hospira Remicade Biosimilar Product and Services
Table 26. Hospira Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Serono (Merck Group) Basic Information, Manufacturing Base and Competitors
Table 28. Merck Serono (Merck Group) Major Business
Table 29. Merck Serono (Merck Group) Remicade Biosimilar Product and Services
Table 30. Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Biogen idec Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Biogen idec Inc. Major Business
Table 33. Biogen idec Inc. Remicade Biosimilar Product and Services
Table 34. Biogen idec Inc. Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Genentech (Roche Group) Basic Information, Manufacturing Base and Competitors
Table 36. Genentech (Roche Group) Major Business
Table 37. Genentech (Roche Group) Remicade Biosimilar Product and Services
Table 38. Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Fosun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Fosun Pharmaceutical Major Business
Table 41. Fosun Pharmaceutical Remicade Biosimilar Product and Services
Table 42. Fosun Pharmaceutical Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Livzon Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Livzon Pharmaceutical Major Business
Table 45. Livzon Pharmaceutical Remicade Biosimilar Product and Services
Table 46. Livzon Pharmaceutical Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 48. Anke Biotechnology Major Business
Table 49. Anke Biotechnology Remicade Biosimilar Product and Services
Table 50. Anke Biotechnology Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 52. Hualan Biological Engineering Major Business
Table 53. Hualan Biological Engineering Remicade Biosimilar Product and Services
Table 54. Hualan Biological Engineering Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 56. Walvax Biotechnology Major Business
Table 57. Walvax Biotechnology Remicade Biosimilar Product and Services
Table 58. Walvax Biotechnology Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Hisun Pharmaceutical Major Business
Table 61. Hisun Pharmaceutical Remicade Biosimilar Product and Services
Table 62. Hisun Pharmaceutical Remicade Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Remicade Biosimilar Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Remicade Biosimilar Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Remicade Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Remicade Biosimilar Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Remicade Biosimilar Production Site of Key Manufacturer
Table 68. Remicade Biosimilar New Entrant and Capacity Expansion Plans
Table 69. Remicade Biosimilar Mergers & Acquisitions in the Past Five Years
Table 70. Global Remicade Biosimilar Sales by Region (2017-2022) & (K Units)
Table 71. Global Remicade Biosimilar Sales by Region (2023-2028) & (K Units)
Table 72. Global Remicade Biosimilar Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Remicade Biosimilar Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Remicade Biosimilar Sales by Type (2017-2022) & (K Units)
Table 75. Global Remicade Biosimilar Sales by Type (2023-2028) & (K Units)
Table 76. Global Remicade Biosimilar Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Remicade Biosimilar Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Remicade Biosimilar Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Remicade Biosimilar Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Remicade Biosimilar Sales by Application (2017-2022) & (K Units)
Table 81. Global Remicade Biosimilar Sales by Application (2023-2028) & (K Units)
Table 82. Global Remicade Biosimilar Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Remicade Biosimilar Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Remicade Biosimilar Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Remicade Biosimilar Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Remicade Biosimilar Sales by Country (2017-2022) & (K Units)
Table 87. North America Remicade Biosimilar Sales by Country (2023-2028) & (K Units)
Table 88. North America Remicade Biosimilar Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Remicade Biosimilar Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Remicade Biosimilar Sales by Type (2017-2022) & (K Units)
Table 91. North America Remicade Biosimilar Sales by Type (2023-2028) & (K Units)
Table 92. North America Remicade Biosimilar Sales by Application (2017-2022) & (K Units)
Table 93. North America Remicade Biosimilar Sales by Application (2023-2028) & (K Units)
Table 94. Europe Remicade Biosimilar Sales by Country (2017-2022) & (K Units)
Table 95. Europe Remicade Biosimilar Sales by Country (2023-2028) & (K Units)
Table 96. Europe Remicade Biosimilar Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Remicade Biosimilar Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Remicade Biosimilar Sales by Type (2017-2022) & (K Units)
Table 99. Europe Remicade Biosimilar Sales by Type (2023-2028) & (K Units)
Table 100. Europe Remicade Biosimilar Sales by Application (2017-2022) & (K Units)
Table 101. Europe Remicade Biosimilar Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Remicade Biosimilar Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Remicade Biosimilar Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Remicade Biosimilar Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Remicade Biosimilar Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Remicade Biosimilar Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Remicade Biosimilar Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Remicade Biosimilar Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Remicade Biosimilar Sales by Application (2023-2028) & (K Units)
Table 110. South America Remicade Biosimilar Sales by Country (2017-2022) & (K Units)
Table 111. South America Remicade Biosimilar Sales by Country (2023-2028) & (K Units)
Table 112. South America Remicade Biosimilar Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Remicade Biosimilar Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Remicade Biosimilar Sales by Type (2017-2022) & (K Units)
Table 115. South America Remicade Biosimilar Sales by Type (2023-2028) & (K Units)
Table 116. South America Remicade Biosimilar Sales by Application (2017-2022) & (K Units)
Table 117. South America Remicade Biosimilar Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Remicade Biosimilar Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Remicade Biosimilar Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Remicade Biosimilar Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Remicade Biosimilar Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Remicade Biosimilar Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Remicade Biosimilar Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Remicade Biosimilar Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Remicade Biosimilar Sales by Application (2023-2028) & (K Units)
Table 126. Remicade Biosimilar Raw Material
Table 127. Key Manufacturers of Remicade Biosimilar Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Remicade Biosimilar Typical Distributors
Table 131. Remicade Biosimilar Typical Customers
List of Figures
Figure 1. Remicade Biosimilar Picture
Figure 2. Global Remicade Biosimilar Revenue Market Share by Type in 2021
Figure 3. 100mg/10ml
Figure 4. 500mg/50ml
Figure 5. Global Remicade Biosimilar Revenue Market Share by Application in 2021
Figure 6. Blood Disorders
Figure 7. Oncology Diseases
Figure 8. Global Remicade Biosimilar Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Remicade Biosimilar Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Remicade Biosimilar Sales (2017-2028) & (K Units)
Figure 11. Global Remicade Biosimilar Price (2017-2028) & (US$/Unit)
Figure 12. Global Remicade Biosimilar Production Capacity (2017-2028) & (K Units)
Figure 13. Global Remicade Biosimilar Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Remicade Biosimilar Market Drivers
Figure 15. Remicade Biosimilar Market Restraints
Figure 16. Remicade Biosimilar Market Trends
Figure 17. Global Remicade Biosimilar Sales Market Share by Manufacturer in 2021
Figure 18. Global Remicade Biosimilar Revenue Market Share by Manufacturer in 2021
Figure 19. Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Remicade Biosimilar Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Remicade Biosimilar Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Remicade Biosimilar Sales Market Share by Region (2017-2028)
Figure 23. Global Remicade Biosimilar Revenue Market Share by Region (2017-2028)
Figure 24. North America Remicade Biosimilar Revenue (2017-2028) & (USD Million)
Figure 25. Europe Remicade Biosimilar Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Remicade Biosimilar Revenue (2017-2028) & (USD Million)
Figure 27. South America Remicade Biosimilar Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Remicade Biosimilar Revenue (2017-2028) & (USD Million)
Figure 29. Global Remicade Biosimilar Sales Market Share by Type (2017-2028)
Figure 30. Global Remicade Biosimilar Revenue Market Share by Type (2017-2028)
Figure 31. Global Remicade Biosimilar Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Remicade Biosimilar Sales Market Share by Application (2017-2028)
Figure 33. Global Remicade Biosimilar Revenue Market Share by Application (2017-2028)
Figure 34. Global Remicade Biosimilar Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Remicade Biosimilar Sales Market Share by Type (2017-2028)
Figure 36. North America Remicade Biosimilar Sales Market Share by Application (2017-2028)
Figure 37. North America Remicade Biosimilar Sales Market Share by Country (2017-2028)
Figure 38. North America Remicade Biosimilar Revenue Market Share by Country (2017-2028)
Figure 39. United States Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Remicade Biosimilar Sales Market Share by Type (2017-2028)
Figure 43. Europe Remicade Biosimilar Sales Market Share by Application (2017-2028)
Figure 44. Europe Remicade Biosimilar Sales Market Share by Country (2017-2028)
Figure 45. Europe Remicade Biosimilar Revenue Market Share by Country (2017-2028)
Figure 46. Germany Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Remicade Biosimilar Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Remicade Biosimilar Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Remicade Biosimilar Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Remicade Biosimilar Revenue Market Share by Region (2017-2028)
Figure 55. China Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Remicade Biosimilar Sales Market Share by Type (2017-2028)
Figure 62. South America Remicade Biosimilar Sales Market Share by Application (2017-2028)
Figure 63. South America Remicade Biosimilar Sales Market Share by Country (2017-2028)
Figure 64. South America Remicade Biosimilar Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Remicade Biosimilar Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Remicade Biosimilar Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Remicade Biosimilar Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Remicade Biosimilar Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Remicade Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Remicade Biosimilar in 2021
Figure 76. Manufacturing Process Analysis of Remicade Biosimilar
Figure 77. Remicade Biosimilar Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
